News | August 09, 2022
Lyka Labs swings back to profit in Q1FY23
The company has reported total income of Rs. 28.20 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 28.20 crores during the period ended June 30, 2022.
Dr. Lal Path Labs has reported total income of Rs. 511 crores during the period ended June 30, 2022
Dr. Reddy's Fesoterodine Fumarate Extended-Release Tablets are available in 4 mg and 8 mg Tablets, each in bottle count sizes of 30.
Merck is organizing one of the biggest South APAC Virtual Conclave on ‘Next-Gen Labs’ on 20th July.
The introduction of Enverse is part of StimLabs' aim to simplify patient care for both physicians and the hospital systems
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
The company has posted net loss of Rs. 67.65 crores for the Financial Year ended March 31, 2022
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs
Pilots to be launched across multiple locations in India.
Subscribe To Our Newsletter & Stay Updated
